Edwards VP Lippis reports 619-share sale
Edwards Lifesciences Vice President Daniel J. Lippis reported selling 619 shares at $85.65 under a 10b5-1 plan, according to Form 4 filings. The filing also showed a same-day exercise of 619 shares at $72.68.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.